NCT06834178Recruiting
Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
Hepatitis Elimination And Liver Care in South-East Austria (HEAL-S)
Source: ClinicalTrials.gov · Last updated 18 Jun 2026
Brief summary (registry, in English)
The HEAL-S study is a non-interventional study with retrospective data analysis. It consists of two parts. First a retrospective analysis based on nucleic acid testing (NAT) results will be performed. Two cohorts (HCV) and (HBV) will be established. Patients falling into one (or both) of the two cohorts will be invited to a prospective linkage-to-care study. In this part, patients are invited to the clinic, where the possibility of hepatitis treatment will be discussed.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 13 Feb 2025
- Start date
- 1 May 2025
- Primary completion date
- Oct 2026
- Lead sponsor
- Vanessa Stadlbauer-Koellner, MD
- Diseases
- Hepatitis B
- NCT number
- NCT06834178
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 May 2025 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Documented Sustained Virological Response (HCV cohort)
- Documented assessment of HDV status (HBV cohort)
Other
- No valid SVRN (german: Sozialversicherungsnummer, english: Social insurance number)
- No contact details available
Who the study is looking for
- The target population for the HCV cohort consists of individuals with detectable plasma HCV RNA at the latest observation.
- The target population for the HBV cohort consists of individuals with detectable plasma HBV RNA at any time and no recorded HDV testing or a positive HDV serology.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Internal Medicine, Division of Gastroenterology and Hepatology Coordinator of this site? Confirm its status | Graz | Austria | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.